maximizing Oncology study with built-in KRAS Assay products and services and RAS Assays
within the fast evolving subject of oncology investigate, correct and successful mutation screening is essential for producing focused therapies. The KRAS Services System plays a pivotal role During this landscape by providing comprehensive methods for KRAS mutation profiling and Evaluation. KRAS mutations, found in close to 95% of RAS-relevant onc